Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...

It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.

South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...

By William Baloyi When President Donald Trump issued an executive order suspending all foreign aid to South Africa, in ...

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...

JOHANNESBURG (AP) — South Africa's health minister on Tuesday called lenacapavir, the first twice-yearly HIV prevention jab in the world, a “groundbreaking” tool to fight the disease, but warned ...

EFF statement on South Africa registering the twice-a-year anti-HIV injection, Lenacapavir ...

The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...

South Africa has become the first African country to register lenacapavir, a groundbreaking six-monthly HIV prevention ...

UMZIMKHULU, South Africa (AP) — At a rural village in South Africa's KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for the one-hour ride ...

JOHANNESBURG (AP) — Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history’s ...

PRETORIA, South Africa (AP) — It’s a worrying question for health officials in one of the richest and most developed areas of the African continent: Why are babies being born with HIV when free ...